Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: CombiMatrix; SQI Diagnostics, Gamma-Dynacare; NuGen; Evotec; WaferGen Biosystems

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix said this week that its subsidiary, CombiMatrix Molecular Diagnostics, has received approval from Medicare to begin billing for its array-based diagnostic tests. The subsidiary offers array-based cancer tests through its Irvine, Calif.-based CLIA-certified lab.

Gamma-Dynacare Medical Laboratories will begin offering SQI Diagnostics' multiplex IgXplex Rheumatoid Arthritis test through its lab services in Canada. The firms are also in discussions for Gamma-Dynacare to beta test SQI's celiac panel.

NuGen said this week that it has received cGMP certification from the State of California for the manufacture and shipping of its RNA and DNA sample preparation products. The firm noted that it had already received ISO 13485 certification.

Evotec said that it will receive a €2.5 million ($3.1 million) milestone payment from Boehringer Ingelheim for selection of a candidate compound for pre-development studies in an oncology program. The firms have been collaborating since 2004 in a variety of disease areas.

WaferGen Biosystems today said that researchers at Kyoto University will use the firm's SmartChip Real-Time PCR System to identify and compare biomarkers that may be associated with tissue regeneration. It noted that Kyoto University is one of the firm's early-access customers for the SmartChip system.

Jackson Laboratory associate research scientist Julie Wells has received a $90,000 grant from the Maine Cancer Foundation for a research titled "MicroRNA expression during lung tumor progression." The grant is part of three awarded by the foundation to Jackson Lab researchers to conduct research into cancer.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.